GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Moderna, Inc. (MRNA) | 11/6/2026 4:19:50 PM | Large | View | Financials | 10-Q | SEC | 3Q 2026 ending: 9/30/2026 | Rev: $1,313,000,000 +29.2% | Assets $13,468,000,000 | EPS $0.38 | |
| Moderna, Inc. (MRNA) | 11/6/2026 6:47:56 AM | View | Financials | Earnings | SEC | 3Q 2026 | Rev $1,313,000,000 +29.2% | Assets $13,468,000,000 | EPS $0.38 | Export Earnings Model | |
| Moderna, Inc. (MRNA) | 7/31/2026 4:25:14 PM | Large | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $145,000,000 +2.1% | Assets $10,961,000,000 | EPS -$1.97 | |
| Moderna, Inc. (MRNA) | 7/31/2026 7:04:42 AM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $145,000,000 +2.1% | Assets $10,961,000,000 | EPS -$1.97 | Export Earnings Model | |
| Moderna, Inc. (MRNA) | 5/1/2026 4:22:12 PM | Large | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $389,000,000 +260.2% | Assets $11,488,000,000 | EPS -$3.40 | |
| Moderna, Inc. (MRNA) | 5/1/2026 9:25:58 AM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $389,000,000 +260.2% | Assets $11,488,000,000 | EPS -$3.40 | Export Earnings Model | |
| Moderna, Inc. (MRNA) | 3/16/2026 4:34:05 PM | View | Proxy | SEC | Y 2025 | ||||||
| Moderna, Inc. (MRNA) | 2/20/2026 4:14:30 PM | Large | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $1,944,000,000 -39.9% | Assets $12,338,000,000 | EPS -$7.26 | |
| Moderna, Inc. (MRNA) | 2/13/2026 7:03:25 AM | View | Financials | Earnings | SEC | Y 2025 | Rev $678,000,000 -29.8% | Assets $12,338,000,000 | EPS -$2.11 | Export Earnings Model | |
| Moderna, Inc. (MRNA) | 1/12/2026 7:02:41 AM | View | Financials | Earnings (Prelim) | SEC | Y 2025 | Export Earnings Model | ||||
| Moderna, Inc. (MRNA) | 11/6/2025 4:14:18 PM | Large | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $1,016,000,000 -45.4% | Assets $12,135,000,000 | EPS -$0.51 | |
| Moderna, Inc. (MRNA) | 11/6/2025 7:04:21 AM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $1,016,000,000 -45.4% | Assets $12,135,000,000 | EPS -$0.51 | Export Earnings Model | |
| Moderna, Inc. (MRNA) | 10/15/2025 8:46:54 AM | View | Proxy | SEC | Y 2024 | ||||||
| Moderna, Inc. (MRNA) | 8/1/2025 4:13:04 PM | Large | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Rev: $142,000,000 -41.1% | Assets $12,010,000,000 | EPS -$2.13 | |
| Moderna, Inc. (MRNA) | 8/1/2025 7:03:08 AM | View | Financials | Earnings | SEC | 2Q 2025 | Rev $142,000,000 -41.1% | Assets $12,010,000,000 | EPS -$2.13 | Export Earnings Model | |
| Moderna, Inc. (MRNA) | 5/1/2025 4:14:43 PM | Large | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $108,000,000 -35.3% | Assets $12,704,000,000 | EPS -$2.52 | |
| Moderna, Inc. (MRNA) | 5/1/2025 6:33:00 AM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $108,000,000 -35.3% | Assets $12,704,000,000 | EPS -$2.52 | Export Earnings Model | |
| Moderna, Inc. (MRNA) | 3/11/2025 4:10:29 PM | View | Proxy | SEC | Y 2024 | ||||||
| Moderna, Inc. (MRNA) | 2/21/2025 7:25:04 AM | Large | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $3,236,000,000 -52.7% | Assets $14,142,000,000 | EPS -$9.28 | |
| Moderna, Inc. (MRNA) | 2/14/2025 6:31:24 AM | View | Financials | Earnings | SEC | Y 2024 | Rev $966,000,000 -65.6% | Assets $14,142,000,000 | EPS -$2.91 | Export Earnings Model | |
| Moderna, Inc. (MRNA) | 1/13/2025 7:23:38 AM | View | Financials | Earnings (Prelim) | SEC | Y 2024 | Export Earnings Model | ||||
| Moderna, Inc. (MRNA) | 11/7/2024 4:13:54 PM | Large | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $1,862,000,000 +1.7% | Assets $15,803,000,000 | EPS $0.03 | |
| Moderna, Inc. (MRNA) | 11/7/2024 6:36:25 AM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $1,862,000,000 +1.7% | Assets $15,803,000,000 | EPS $0.03 | Export Earnings Model | |
| Moderna, Inc. (MRNA) | 8/1/2024 4:17:22 PM | Large | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $241,000,000 -29.9% | Assets $15,680,000,000 | EPS -$3.33 | |
| Moderna, Inc. (MRNA) | 8/1/2024 6:32:47 AM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $241,000,000 -29.9% | Assets $15,680,000,000 | EPS -$3.33 | Export Earnings Model | |
| Moderna, Inc. (MRNA) | 5/2/2024 4:19:41 PM | Large | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $167,000,000 -91.0% | Assets $16,729,000,000 | EPS -$3.07 | |
| Moderna, Inc. (MRNA) | 5/2/2024 6:33:01 AM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $167,000,000 -91.0% | Assets $16,729,000,000 | EPS -$3.07 | Export Earnings Model | |
| Moderna, Inc. (MRNA) | 3/21/2024 8:48:15 AM | View | Proxy | SEC | Y 2023 | ||||||
| Moderna, Inc. (MRNA) | 2/23/2024 4:17:03 PM | Large | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $6,848,000,000 -64.4% | Assets $18,426,000,000 | EPS -$12.33 | |
| Moderna, Inc. (MRNA) | 2/22/2024 6:32:56 AM | View | Financials | Earnings | SEC | Y 2023 | Rev $2,811,000,000 -44.7% | Assets $18,426,000,000 | EPS $0.56 | Export Earnings Model | |
| Moderna, Inc. (MRNA) | 1/8/2024 7:04:49 AM | View | Financials | Earnings (Prelim) | SEC | Y 2023 | Export Earnings Model | ||||
| Moderna, Inc. (MRNA) | 11/3/2023 4:18:58 PM | Large | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $1,831,000,000 -45.6% | Assets $19,450,000,000 | EPS -$9.53 | |
| Moderna, Inc. (MRNA) | 11/2/2023 6:35:17 AM | View | Financials | Earnings | SEC | 3Q 2023 | Rev $1,831,000,000 -45.6% | Assets $19,450,000,000 | EPS -$9.53 | Export Earnings Model | |
| Moderna, Inc. (MRNA) | 8/3/2023 4:18:19 PM | Large | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $344,000,000 -92.8% | Assets $21,884,000,000 | EPS -$3.62 | |
| Moderna, Inc. (MRNA) | 8/3/2023 6:35:38 AM | View | Financials | Earnings | SEC | 2Q 2023 | Rev $344,000,000 -92.8% | Assets $21,884,000,000 | EPS -$3.62 | Export Earnings Model | |
| Moderna, Inc. (MRNA) | 5/4/2023 4:10:45 PM | Large | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $1,862,000,000 -69.3% | Assets $24,125,000,000 | EPS $0.19 | |
| Moderna, Inc. (MRNA) | 5/4/2023 6:36:02 AM | View | Financials | Earnings | SEC | 1Q 2023 | Rev $1,862,000,000 -69.3% | Assets $24,125,000,000 | EPS $0.19 | Export Earnings Model | |
| Moderna, Inc. (MRNA) | 3/15/2023 4:29:58 PM | View | Proxy | SEC | Y 2022 | ||||||
| Moderna, Inc. (MRNA) | 2/24/2023 4:20:27 PM | Large | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $19,263,000,000 +4.3% | Assets $25,858,000,000 | EPS $20.12 | |
| Moderna, Inc. (MRNA) | 2/23/2023 7:05:55 AM | View | Financials | Earnings | SEC | Y 2022 | Rev $5,084,000,000 -29.5% | Assets $25,858,000,000 | EPS $3.66 | Export Earnings Model | |
| Moderna, Inc. (MRNA) | 1/9/2023 7:04:40 AM | View | Financials | Earnings (Prelim) | SEC | Y 2022 | Export Earnings Model | ||||
| Moderna, Inc. (MRNA) | 11/4/2022 4:02:25 AM | Large | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $3,364,000,000 -32.3% | Assets $26,056,000,000 | EPS $2.53 | |
| Moderna, Inc. (MRNA) | 11/3/2022 7:07:20 AM | View | Financials | Earnings | SEC | 3Q 2022 | Rev $3,364,000,000 -32.3% | Assets $26,056,000,000 | EPS $2.53 | Export Earnings Model | |
| Moderna, Inc. (MRNA) | 8/3/2022 4:15:17 PM | Large | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Rev: $4,749,000,000 +9.1% | Assets $26,043,000,000 | EPS $5.24 | |
| Moderna, Inc. (MRNA) | 8/3/2022 7:05:57 AM | View | Financials | Earnings | SEC | 2Q 2022 | Rev $4,749,000,000 +9.1% | Assets $26,043,000,000 | EPS $5.24 | Export Earnings Model | |
| Moderna, Inc. (MRNA) | 5/4/2022 4:20:41 PM | Large | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $6,066,000,000 +213.2% | Assets $27,609,000,000 | EPS $8.58 | |
| Moderna, Inc. (MRNA) | 5/4/2022 7:00:06 AM | View | Financials | Earnings | SEC | 1Q 2022 | Rev $6,066,000,000 +213.2% | Assets $27,609,000,000 | EPS $8.58 | Export Earnings Model | |
| Moderna, Inc. (MRNA) | 3/9/2022 4:18:57 PM | View | Proxy | SEC | Y 2021 | ||||||
| Moderna, Inc. (MRNA) | 2/25/2022 8:22:51 AM | Large | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $18,471,000,000 +2,200.2% | Assets $24,669,000,000 | EPS $28.29 | |
| Moderna, Inc. (MRNA) | 2/24/2022 7:18:46 AM | View | Financials | Earnings | SEC | Y 2021 | Rev $7,211,000,000 +1,162.9% | Assets $24,669,000,000 | EPS $11.29 | Export Earnings Model | |
| Moderna, Inc. (MRNA) | 1/10/2022 7:23:39 AM | View | Financials | Earnings (Prelim) | SEC | Y 2021 | Export Earnings Model | ||||
| Moderna, Inc. (MRNA) | 1/4/2022 8:02:31 AM | View | Financials | Earnings (Prelim) | SEC | Y 2021 | Export Earnings Model | ||||
| Moderna, Inc. (MRNA) | 11/4/2021 5:05:15 PM | Large | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $4,969,000,000 +3,065.0% | Assets $20,923,000,000 | EPS $7.70 | |
| Moderna, Inc. (MRNA) | 11/4/2021 7:08:07 AM | View | Financials | Earnings | SEC | 3Q 2021 | Rev $4,969,000,000 +3,065.0% | Assets $20,923,000,000 | EPS $7.70 | Export Earnings Model | |
| Moderna, Inc. (MRNA) | 8/5/2021 4:26:32 PM | Large | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $4,354,000,000 +6,398.5% | Assets $16,153,000,000 | EPS $6.46 | |
| Moderna, Inc. (MRNA) | 8/5/2021 6:43:07 AM | View | Financials | Earnings | SEC | 2Q 2021 | Rev $4,354,000,000 +6,398.5% | Assets $16,153,000,000 | EPS $6.46 | Export Earnings Model | |
| Moderna, Inc. (MRNA) | 5/6/2021 4:42:36 PM | Large | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $1,937,000,000 +24,112.5% | Assets $12,694,000,000 | EPS $2.84 | |
| Moderna, Inc. (MRNA) | 5/6/2021 7:30:16 AM | View | Financials | Earnings | SEC | 1Q 2021 | Rev $1,937,000,000 +24,112.5% | Assets $12,694,000,000 | EPS $2.84 | Export Earnings Model | |
| Moderna, Inc. (MRNA) | 3/10/2021 4:43:04 PM | View | Proxy | SEC | Y 2020 | ||||||
| Moderna, Inc. (MRNA) | 2/26/2021 5:14:56 PM | Large | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Rev: $803,000,000 +1,238.3% | Assets $7,337,000,000 | EPS -$1.96 | |
| Moderna, Inc. (MRNA) | 2/25/2021 7:10:10 AM | View | Financials | Earnings | SEC | Y 2020 | Rev $571,000,000 +3,962.6% | Assets $7,337,000,000 | EPS -$0.70 | Export Earnings Model | |
| Moderna, Inc. (MRNA) | 10/30/2020 8:38:02 AM | Large | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Rev: $157,000,000 +821.0% | Assets $4,650,873,000 | EPS -$0.59 | |
| Moderna, Inc. (MRNA) | 10/29/2020 7:07:33 AM | View | Financials | Earnings | SEC | 3Q 2020 | Rev $157,000,000 +821.0% | Assets $4,650,873,000 | EPS -$0.59 | Export Earnings Model | |
| Moderna, Inc. (MRNA) | 8/6/2020 4:52:52 PM | Large | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Rev: $67,000,000 +412.1% | Assets $3,486,006,000 | EPS -$0.31 | |
| Moderna, Inc. (MRNA) | 8/5/2020 7:23:57 AM | View | Financials | Earnings | SEC | 2Q 2020 | Rev $67,000,000 +412.1% | Assets $3,486,006,000 | EPS -$0.31 | Export Earnings Model | |
| Moderna, Inc. (MRNA) | 5/7/2020 4:14:19 PM | Mid | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Rev: $8,000,000 -50.1% | Assets $2,067,541,000 | EPS -$0.35 | |
| Moderna, Inc. (MRNA) | 5/7/2020 7:15:48 AM | View | Financials | Earnings | SEC | 1Q 2020 | Rev $8,000,000 -50.1% | Assets $2,067,541,000 | EPS -$0.35 | Export Earnings Model | |
| Moderna, Inc. (MRNA) | 3/16/2020 7:04:31 AM | View | Proxy | SEC | Y 2019 | ||||||
| Moderna, Inc. (MRNA) | 2/27/2020 4:57:19 PM | Mid | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Rev: $60,000,000 -55.6% | Assets $1,589,422,000 | EPS -$1.55 | |
| Moderna, Inc. (MRNA) | 2/26/2020 7:14:22 AM | View | Financials | Earnings | SEC | Y 2019 | Rev $14,055,000 -60.3% | Assets $1,589,422,000 | EPS -$0.36 | Export Earnings Model | |
| Moderna, Inc. (MRNA) | 11/6/2019 4:58:44 PM | Mid | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Rev: $17,046,000 -59.2% | Assets $1,590,899,000 | EPS -$0.37 | |
| Moderna, Inc. (MRNA) | 11/6/2019 7:02:18 AM | View | Financials | Earnings | SEC | 3Q 2019 | Rev $17,046,000 -59.2% | Assets $1,590,899,000 | EPS -$0.37 | Export Earnings Model | |
| Moderna, Inc. (MRNA) | 8/8/2019 4:37:21 PM | Mid | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Rev: $13,083,000 -54.7% | Assets $1,685,279,000 | EPS -$0.41 | |
| Moderna, Inc. (MRNA) | 8/7/2019 7:00:15 AM | View | Financials | Earnings | SEC | 2Q 2019 | Rev $13,083,000 -54.7% | Assets $1,685,279,000 | EPS -$0.41 | Export Earnings Model | |
| Moderna, Inc. (MRNA) | 5/15/2019 5:38:40 PM | View | Proxy | SEC | Y 2018 | ||||||
| Moderna, Inc. (MRNA) | 5/9/2019 5:01:36 PM | Mid | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Rev: $16,025,000 -44.8% | Assets $1,806,207,000 | EPS -$0.40 | |
| Moderna, Inc. (MRNA) | 5/9/2019 6:16:13 AM | View | Correction | SEC | 1Q 2019 | ||||||
| Moderna, Inc. (MRNA) | 5/8/2019 7:01:43 AM | View | Financials | Earnings | SEC | 1Q 2019 | Rev $16,025,000 -44.8% | Assets $1,806,207,000 | EPS -$0.40 | Export Earnings Model | |
| Moderna, Inc. (MRNA) | 3/13/2019 4:43:01 PM | Mid | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Rev: $135,068,000 -34.4% | Assets $2,019,962,000 | EPS -$4.95 | |
| Moderna, Inc. (MRNA) | 3/6/2019 7:09:36 AM | View | Financials | Earnings | SEC | Y 2018 | Rev $35,421,000 -61.5% | Assets $2,019,962,000 | EPS -$1.14 | Export Earnings Model | |
| Moderna, Inc. (MRNA) | 1/8/2019 8:31:27 AM | View | Earnings (Prelim) | SEC | Y 2018 | ||||||
| Moderna, Inc. (MRNA) | 1/8/2019 8:30:33 AM | View | Financials | Earnings (Prelim) | SEC | Y 2018 | Export Earnings Model |